摘要
全球医药产业增速变缓促使国际医药巨头加大对生物医药产业的投资。生物医药在全球范围内掀起研发热潮,中国作为新兴市场的主力,表现尤为抢眼。抗体、疫苗、重组蛋白三大主力生物医药产品在销售额和上榜数量上不断刷新全球畅销药品榜单。我国生物医药产业起步虽晚,但已获长足进展。该文从生物医药研发、市场、企业层面报告了国内外生物医药产业现状。
The slowdown of global pharmaceutical market growth urge global pharmaceutical giants to increase investment for the biomedical industry.A research and development wave is upsurging in the global biomedical industry.As the most eye-catching emerging market,China's three major biopharmaceutical products,antibodies,vaccines and recombinant proteins,are constantly refreshing the list of best-selling drugs every year.Biomedical industry in China started only in recent years,but have already shown substantial progress.This paper aims to give an overview of the current status of biomedical industry both in China and abroad in terms of R&D,market and enterprises.
出处
《精细与专用化学品》
CAS
2014年第7期1-6,共6页
Fine and Specialty Chemicals
关键词
生物医药
研发投入
抗体
重组蛋白
疫苗
biomedicine
research capital
antibody
recombinant protein
vaccine
